Resumen
Bilirubin has several physiological functions, both beneficial and harmful. In addition to reactive oxygen species-scavenging activities, bilirubin has potent immunosuppressive effects associated with long-term pathophysiological sequelae. It has been recently recognized as a hormone with endocrine actions and interconnected effects on various cellular signaling pathways. Current studies show that bilirubin also decreases adiposity and prevents metabolic and cardiovascular diseases. All in all, the physiological importance of bilirubin is only now coming to light, and strategies for increasing plasma bilirubin levels to combat chronic diseases are starting to be considered. This review discusses the beneficial effects of increasing plasma bilirubin, incorporates emerging areas of bilirubin biology, and provides key concepts to advance the field.
| Idioma original | English |
|---|---|
| Páginas (desde-hasta) | 315-328 |
| Número de páginas | 14 |
| Publicación | Trends in Molecular Medicine |
| Volumen | 29 |
| N.º | 4 |
| DOI | |
| Estado | Published - abr 2023 |
Nota bibliográfica
Publisher Copyright:© 2023 Elsevier Ltd
Financiación
This work was supported by National Institutes of Health grants R01DK121797 (to T.D.H.) and R01DK126884 (D.E.S.), National Heart, Lung and Blood Institute P01 HL05197-11 (D.E.S.) and K01HL125445 (T.D.H.), and National Institute of General Medical Sciences P20GM104357-02 (D.E.S.). This study was supported by grants MH CZ-DRO-VFN64165 (to L.V.) from the Czech Ministry of Health , Cooperation Program, research area DIAG provided by Charles University , and the project National Institute for Research of Metabolic and Cardiovascular Diseases (Programme EXCELES LX22NPO5104 ) funded by the EU – 'Next Generation EU' .
| Financiadores | Número del financiador |
|---|---|
| National Institutes of Health (NIH) | R01DK126884, R01DK121797 |
| National Heart, Lung, and Blood Institute (NHLBI) | K01HL125445, P01 HL05197-11 |
| National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical Sciences | P20GM104357-02, MH CZ-DRO-VFN64165 |
| Univerzita Karlova v Praze | LX22NPO5104 |
| European Commission | |
| Ministerstvo Zdravotnictví Ceské Republiky |
ODS de las Naciones Unidas
Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible
-
Good health and well being
ASJC Scopus subject areas
- Molecular Medicine
- Molecular Biology
Huella
Profundice en los temas de investigación de 'The physiology of bilirubin: health and disease equilibrium'. En conjunto forman una huella única.Citar esto
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver